Euro vs US Dollar

Registrieren Sie sich, um in unseren aktiven Foren mit gleichgesinnten Anlegern zu diskutieren.

Registrieren

AIM AIM ImmunoTech Inc

0,19

-0,0404 (-17,53%)

20 Nov 2024 - Geschlossen

Verzögert um 15 Minuten

Form SC 13G - Statement of Beneficial Ownership by Certain Investors

null

AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
Von Okt 2024 bis Nov 2024

Click Here for more AIM ImmunoTech Charts.

AIM ImmunoTech (AMEX:AIM)
Historical Stock Chart
Von Nov 2023 bis Nov 2024

Click Here for more AIM ImmunoTech Charts.

News AIM ImmunoTech Inc

Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
Dienstag 19 November 2024 (4 Stunden vor) • Edgar (US Regulatory)

AIM ImmunoTech Announces Publication of Breast Cancer Data from Roswell Park Comprehensive Cancer Center in The Journal for ImmunoTherapy of Cancer
Dienstag 19 November 2024 (12 Stunden vor) • GlobeNewswire Inc.

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 15 November 2024 (4 Tage vor) • Edgar (US Regulatory)

Form S-1 - General form for registration of securities under the Securities Act of 1933
Freitag 15 November 2024 (4 Tage vor) • Edgar (US Regulatory)

AIM ImmunoTech Reports Third Quarter 2024 Financial Results and Provides Corporate Update
Freitag 15 November 2024 (5 Tage vor) • GlobeNewswire Inc.

Form 10-Q - Quarterly report [Sections 13 or 15(d)]
Donnerstag 14 November 2024 (5 Tage vor) • Edgar (US Regulatory)

Form DFAN14A - Additional definitive proxy soliciting materials filed by non-management and Rule 14(a)(12) material
Donnerstag 14 November 2024 (5 Tage vor) • Edgar (US Regulatory)

Form SC 13G - Statement of Beneficial Ownership by Certain Investors
Donnerstag 14 November 2024 (5 Tage vor) • Edgar (US Regulatory)

Form DEFA14A - Additional definitive proxy soliciting materials and Rule 14(a)(12) material
Freitag 8 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

Form DEFC14A - Definitive proxy statement, contested solicitations
Mittwoch 6 November 2024 (2 Wochen vor) • Edgar (US Regulatory)

AIM ImmunoTech to Discuss Third Quarter 2024 Financial Results on November 15, 2024 and Host Conference Call and Webcast
Mittwoch 6 November 2024 (2 Wochen vor) • GlobeNewswire Inc.

AIM ImmunoTech Files Definitive Proxy Statement and Sends Letter to Shareholders
Montag 4 November 2024 (2 Wochen vor) • Business Wire

Weitere AIM ImmunoTech Inc News-Artikel

Fisher James And Sons

North Dallas Bank (PK)

Delayed Upgrade Clock

Support: +44 (0) 203 8794 460 | support@advfn.de

Durch das Benutzen des ADVFN Angebotes akzeptieren Sie folgende Allgemeine Geschäftsbedingungen